Share this post on:

Product Name :
KAN-0438757

Search keywords :
KAN0438757

drugId :
null

Target Vo:
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3

Target Vo Short Name :
PFKFB3

Moa_Name:
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kancera

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
c-Kit Rabbit mAb In stock
TBK1 Mouse mAb In stock
p53 Antibody (YA250): p53 Antibody (YA250) is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to p53. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related